Advertisement

Airway Hyperresponsiveness in Asthma: Measurement and Clinical Relevance

Published:February 02, 2017DOI:https://doi.org/10.1016/j.jaip.2016.11.030
      Airway hyperresponsiveness is a characteristic feature of asthma, and its measurement is an important tool in its diagnosis. With a few caveats, methacholine bronchial provocation by a 2-minute tidal breathing method is highly sensitive; a negative test result (PC20 > 16 mg/mL, PD20 > 400 μg) rules out current asthma with reasonable certainty. A PC20 value of less than 1 mg/mL/PD20 value of less than 25 μg is highly specific (ie, diagnostic) but quite insensitive for asthma. For accurate interpretation of the test results, it is important to control and standardize technical factors that have an impact on nebulizer performance. In addition to its utility to relate symptoms such as cough, wheeze, and shortness of breath to variable airflow obstruction (ie, to diagnose current asthma), the test is useful to make a number of other clinical assessments. These include (1) evaluation of patients with occupational asthma, (2) evaluation of patients with exercise-induced respiratory symptoms, (3) evaluation of novel asthma medications, (4) evaluation of relative potency of inhaled bronchodilators, (5) as a biomarker to adjust anti-inflammatory therapy to improve clinical outcomes, and (6) in the evaluation of patients with severe asthma to rule out masqueraders such as laryngeal dysfunction. The actual mechanism of altered smooth muscle behavior in asthma that is assessed by direct (eg, methacholine) or indirect (eg, allergen) bronchial provocation remains one of the most fundamental questions related to asthma that needs to be determined. The test is underutilized in clinical practice.

      Key words

      Abbreviations used:

      AHR (Airway hyperresponsiveness), APSD (Aerosol particle size distribution), EIB (Exercise-induced bronchoconstriction), EVH (Eucapnic voluntary hyperpnea), ICS (Inhaled corticosteroid), OA (Occupational asthma), TSLP (Thymic stromal lymphopoietin)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal

      Subscribe:

      Subscribe to The Journal of Allergy and Clinical Immunology: In Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Tiffeneau R.
        • Beauvallet M.
        Epreuve de bronchoconstriction et de bronchodilation par aerosols.
        Bull Acad Med. 1945; 129: 165-168
        • Curry J.J.
        The action of histamine on the respiratory tract in normal and asthmatic subjects.
        J Clin Invest. 1946; 25: 785-791
        • Orehek J.
        • Gayrard P.
        • Grimaud C.
        • Charpin J.
        Effect of maximal respiratory manoeuvres on bronchial sensitivity of asthmatic patients as compared to normal people.
        Br Med J. 1975; 1: 123-125
        • Cockcroft D.W.
        • Killian D.N.
        • Mellon J.J.
        • Hargreave F.E.
        Bronchial reactivity to inhaled histamine: a method and clinical survey.
        Clin Allergy. 1977; 7: 235-243
        • Beasley R.C.
        • Featherstone R.L.
        • Church M.K.
        • Rafferty P.
        • Varley J.G.
        • Harris A.
        • et al.
        Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction.
        J Appl Physiol. 1989; 66: 1685-1693
        • Thomson N.C.
        • Roberts R.
        • Bandouvakis J.
        • Newball H.
        • Hargreave F.E.
        Comparison of bronchial responses to prostaglandin F2 alpha and methacholine.
        J Allergy Clin Immunol. 1981; 68: 392-398
        • Adelroth E.
        • Morris M.M.
        • Hargreave F.E.
        • O'Byrne P.M.
        Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls.
        N Engl J Med. 1986; 315: 480-484
      1. Hargreave F.E. Airway reactivity: mechanisms and clinical relevance. Astra Pharmaceuticals Canada, Mississagua, Canada1980
        • Parameswaran K.
        • Janssen L.J.
        • O'Byrne P.M.
        Airway hyperresponsiveness and calcium handling by smooth muscle: a “deeper look”.
        Chest. 2002; 121: 621-624
        • Lambert R.K.
        • Wiggs B.R.
        • Kuwano K.
        • Hogg J.C.
        • Pare P.D.
        Functional significance of increased airway smooth muscle in asthma and COPD.
        J Appl Physiol. 1993; 74: 2771-2781
        • Fredberg J.J.
        • Inouye D.
        • Miller B.
        • Nathan M.
        • Jafari S.
        • Raboudi S.H.
        • et al.
        Airway smooth muscle, tidal stretches, and dynamically determined contractile states.
        Am J Respir Crit Care Med. 1997; 156: 1752-1759
        • Ding D.J.
        • Martin J.G.
        • Macklem P.T.
        Effects of lung volume on maximal methacholine-induced bronchoconstriction in normal humans.
        J Appl Physiol. 1987; 62: 1324-1330
        • Hirota N.
        • Martin J.G.
        Mechanisms of airway remodeling.
        Chest. 2013; 144: 1026-1032
        • Carroll N.
        • Elliot J.
        • Morton A.
        • James A.
        The structure of large and small airways in nonfatal and fatal asthma.
        Am Rev Respir Dis. 1993; 147: 405-410
        • James A.L.
        • Elliot J.G.
        • Jones R.L.
        • Carroll M.L.
        • Mauad T.
        • Bai T.R.
        • et al.
        Airway smooth muscle hypertrophy and hyperplasia in asthma.
        Am J Respir Crit Care Med. 2012; 185: 1058-1064
        • Hassan M.
        • Jo T.
        • Risse P.A.
        • Tolloczko B.
        • Lemiere C.
        • Olivenstein R.
        • et al.
        Airway smooth muscle remodeling is a dynamic process in severe long-standing asthma.
        J Allergy Clin Immunol. 2010; 125: 1037-1045.e3
        • Woodruff P.G.
        • Dolganov G.M.
        • Ferrando R.E.
        • Donnelly S.
        • Hays S.R.
        • Solberg O.D.
        • et al.
        Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression.
        Am J Respir Crit Care Med. 2004; 169: 1001-1006
        • Leguillette R.
        • Laviolette M.
        • Bergeron C.
        • Zitouni N.
        • Kogut P.
        • Solway J.
        • et al.
        Myosin, transgelin, and myosin light chain kinase: expression and function in asthma.
        Am J Respir Crit Care Med. 2009; 179: 194-204
        • Ijpma G.
        • Kachmar L.
        • Matusovsky O.S.
        • Bates J.H.
        • Benedetti A.
        • Martin J.G.
        • et al.
        Human trachealis and main bronchi smooth muscle are normoresponsive in asthma.
        Am J Respir Crit Care Med. 2015; 191: 884-893
        • Lee-Gosselin A.
        • Gendron D.
        • Blanchet M.R.
        • Marsolais D.
        • Bosse Y.
        The gain of smooth muscle's contractile capacity induced by tone on in vivo airway responsiveness in mice.
        J Appl Physiol. 2015; 118: 692-698
        • Cockcroft D.
        • Davis B.
        Direct and indirect challenges in the clinical assessment of asthma.
        Ann Allergy Asthma Immunol. 2009; 103 (quiz 9-72, 400): 363-369
        • Pauwels R.
        • Joos G.
        • Van der Straeten M.
        Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma.
        Clin Allergy. 1988; 18: 317-321
        • Crapo R.O.
        • Casaburi R.
        • Coates A.L.
        • Enright P.L.
        • Hankinson J.L.
        • Irvin C.G.
        • et al.
        Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.
        Am J Respir Crit Care Med. 2000; 161: 309-329
        • Juniper E.F.
        • Frith P.A.
        • Dunnett C.
        • Cockcroft D.W.
        • Hargreave F.E.
        Reproducibility and comparison of responses to inhaled histamine and methacholine.
        Thorax. 1978; 33: 705-710
        • Ryan G.
        • Dolovich M.B.
        • Roberts R.S.
        • Frith P.A.
        • Juniper E.F.
        • Hargreave F.E.
        • et al.
        Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared.
        Am Rev Respir Dis. 1981; 123: 195-199
        • Cockcroft D.W.
        • Davis B.E.
        • Todd D.C.
        • Smycniuk A.J.
        Methacholine challenge: comparison of two methods.
        Chest. 2005; 127: 839-844
        • Prieto L.
        • Ferrer A.
        • Domenech J.
        • Perez-Frances C.
        Effect of challenge method on sensitivity, reactivity, and maximal response to methacholine.
        Ann Allergy Asthma Immunol. 2006; 97: 175-181
        • Todd D.C.
        • Davis B.E.
        • Hurst T.S.
        • Cockcroft D.W.
        Dosimeter methacholine challenge: comparison of maximal versus submaximal inhalations.
        J Allergy Clin Immunol. 2004; 114: 517-519
        • Cockcroft D.W.
        • Davis B.E.
        The bronchoprotective effect of inhaling methacholine by using total lung capacity inspirations has a marked influence on the interpretation of the test result.
        J Allergy Clin Immunol. 2006; 117: 1244-1248
        • Cockcroft D.W.
        • Hurst T.S.
        • Gore B.P.
        Importance of evaporative water losses during standardized nebulized inhalation provocation tests.
        Chest. 1989; 96: 505-508
        • Drotar D.E.
        • Davis B.E.
        • Cockcroft D.W.
        Dose versus concentration of methacholine.
        Ann Allergy Asthma Immunol. 1999; 83: 229-230
        • Dell S.D.
        • Bola S.S.
        • Foty R.G.
        • Marshall L.C.
        • Nelligan K.A.
        • Coates A.L.
        Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers.
        Ann Am Thorac Soc. 2015; 12: 357-363
        • Cockcroft D.W.
        • Murdock K.Y.
        • Berscheid B.A.
        • Gore B.P.
        Sensitivity and specificity of histamine PC20 determination in a random selection of young college students.
        J Allergy Clin Immunol. 1992; 89: 23-30
        • Cockcroft D.W.
        • Mink J.T.
        Isocyanate-induced asthma in an automobile spray painter.
        Can Med Assoc J. 1979; 121: 602-604
        • Cockcroft D.W.
        • Hargreave F.E.
        Airway hyperresponsiveness: relevance of random population data to clinical usefulness.
        Am Rev Respir Dis. 1990; 142: 497-500
        • Ramsdale E.H.
        • Morris M.M.
        • Roberts R.S.
        • Hargreave F.E.
        Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness.
        Thorax. 1984; 39: 912-918
        • Verma V.K.
        • Cockcroft D.W.
        • Dosman J.A.
        Airway responsiveness to inhaled histamine in chronic obstructive airways disease: chronic bronchitis vs emphysema.
        Chest. 1988; 94: 457-461
        • Irwin R.S.
        • French C.T.
        • Smyrnios N.A.
        • Curley F.J.
        Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma.
        Arch Intern Med. 1997; 157: 1981-1987
        • Gibson P.G.
        • Dolovich J.
        • Denburg J.
        • Ramsdale E.H.
        • Hargreave F.E.
        Chronic cough: eosinophilic bronchitis without asthma.
        Lancet. 1989; 1: 1346-1348
        • Holzer K.
        • Anderson S.D.
        • Douglass J.
        Exercise in elite summer athletes: challenges for diagnosis.
        J Allergy Clin Immunol. 2002; 110: 374-380
        • Dolovich M.B.
        • Cockcroft D.W.
        • Coates G.
        Aerosols in diagnosis: ventilation, airway penetrance, epithelial permeability, mucociliary transport and airway responsiveness.
        in: Moren F. Dolovich M.B. Newhouse M.T. Newman S.P. Aerosols in medicine: principles, diagnosis and therapy. 2nd ed. Elsevier Science, Amsterdam1993: 195-234
        • Colombo G.
        • Terzano C.
        • Colombo P.
        • Petroianni A.
        • Ricci A.
        • Buttini F.
        Methacholine dry powder inhaler as a new tool for bronchial challenge test.
        Int J Pharm. 2008; 352: 165-171
        • Wright B.M.
        A new nebuliser.
        Lancet. 1958; 2: 24-25
        • Chai H.
        • Farr R.S.
        • Froehlich L.A.
        • Mathison D.A.
        • McLean J.A.
        • Rosenthal R.R.
        • et al.
        Standardization of bronchial inhalation challenge procedures.
        J Allergy Clin Immunol. 1975; 56: 323-327
        • Dhand R.
        Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol.
        Respir Care. 2002; 47 (discussion 1416-8): 1406-1416
        • Ibrahim M.
        • Verma R.
        • Garcia-Contreras L.
        Inhalation drug delivery devices: technology update.
        Med Devices (Auckl). 2015; 8: 131-139
        • Ryan G.
        • Dolovich M.B.
        • Obminski G.
        • Cockcroft D.W.
        • Juniper E.
        • Hargreave F.E.
        • et al.
        Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation.
        J Allergy Clin Immunol. 1981; 67: 156-161
        • Dolovich M.A.
        Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung.
        Respir Care. 2000; 45: 597-608
        • Dolovich M.B.
        Assessing nebulizer performance.
        Respir Care. 2002; 47 (discussion 1301-304): 1290-1301
        • Mercer T.T.
        Production and characterization of aerosols.
        Arch Intern Med. 1973; 131: 39-50
        • Dolovich M.
        • Labiris R.
        Imaging drug delivery and drug responses in the lung.
        Proc Am Thorac Soc. 2004; 1: 329-337
        • Tarlo S.M.
        • Balmes J.
        • Balkissoon R.
        • Beach J.
        • Beckett W.
        • Bernstein D.
        • et al.
        Diagnosis and management of work-related asthma: American College of Chest Physicians Consensus Statement.
        Chest. 2008; 134: 1S-41S
        • Beach J.
        • Russell K.
        • Blitz S.
        • Hooton N.
        • Spooner C.
        • Lemiere C.
        • et al.
        A systematic review of the diagnosis of occupational asthma.
        Chest. 2007; 131: 569-578
        • Pralong J.A.
        • Lemiere C.
        • Rochat T.
        • L'Archeveque J.
        • Labrecque M.
        • Cartier A.
        Predictive value of nonspecific bronchial responsiveness in occupational asthma.
        J Allergy Clin Immunol. 2016; 137: 412-416
        • Lemiere C.
        • Weytjens K.
        • Cartier A.
        • Malo J.L.
        Late asthmatic reaction with airway inflammation but without airway hyperresponsiveness.
        Clin Exp Allergy. 2000; 30: 415-417
        • Yacoub M.R.
        • Perfetti L.
        • Pignatti P.
        • Frascaroli M.
        • Caminati M.
        • Moscato G.
        Usefulness of induced sputum in investigating occupational asthma with normal responsiveness to methacholine: a case report.
        J Allergy Clin Immunol. 2008; 122: 831-832
        • Vandenplas O.
        • Delwiche J.P.
        • Jamart J.
        • Van de Weyer R.
        Increase in non-specific bronchial hyperresponsiveness as an early marker of bronchial response to occupational agents during specific inhalation challenges.
        Thorax. 1996; 51: 472-478
        • Malo J.L.
        • Zunzunegui M.V.
        • L'Archeveque J.
        • Cardinal S.
        • Ghezzo H.
        Direct costs of occupational asthma due to sensitization in Quebec (1988 to 2002): revisited.
        Can Respir J. 2011; 18: e1-e5
        • Malo J.L.
        • Ghezzo H.
        Recovery of methacholine responsiveness after end of exposure in occupational asthma.
        Am J Respir Crit Care Med. 2004; 169: 1304-1307
        • Malo J.L.
        • Cartier A.
        • Ghezzo H.
        • Lafrance M.
        • McCants M.
        • Lehrer S.B.
        Patterns of improvement in spirometry, bronchial hyperresponsiveness, and specific IgE antibody levels after cessation of exposure in occupational asthma caused by snow-crab processing.
        Am Rev Respir Dis. 1988; 138: 807-812
        • Weiler J.M.
        • Anderson S.D.
        • Randolph C.
        • Bonini S.
        • Craig T.J.
        • Pearlman D.S.
        • et al.
        Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter.
        Ann Allergy Asthma Immunol. 2010; 105: S1-S47
        • Kippelen P.
        • Anderson S.D.
        Pathogenesis of exercise-induced bronchoconstriction.
        Immunol Allergy Clin North Am. 2013; 33 (vii): 299-312
        • Finnerty J.P.
        • Holgate S.T.
        The contribution of histamine release and vagal reflexes, alone and in combination, to exercise-induced asthma.
        Eur Respir J. 1993; 6: 1132-1137
        • Duong M.
        • Subbarao P.
        • Adelroth E.
        • Obminski G.
        • Strinich T.
        • Inman M.
        • et al.
        Sputum eosinophils and the response of exercise-induced bronchoconstriction to corticosteroid in asthma.
        Chest. 2008; 133: 404-411
        • Anderson W.J.
        • Lipworth B.J.
        Relationship of mannitol challenge to methacholine challenge and inflammatory markers in persistent asthmatics receiving inhaled corticosteroids.
        Lung. 2012; 190: 513-521
        • Nielsen E.W.
        • Hull J.H.
        • Backer V.
        High prevalence of exercise-induced laryngeal obstruction in athletes.
        Med Sci Sports Exerc. 2013; 45: 2030-2035
        • Inman M.D.
        • Watson R.M.
        • Killian K.J.
        • O'Byrne P.M.
        Methacholine airway responsiveness decreases during exercise in asthmatic subjects.
        Am Rev Respir Dis. 1990; 141: 1414-1417
        • Gauvreau G.M.
        • Ronnen G.M.
        • Watson R.M.
        • O'Byrne P.M.
        Exercise-induced bronchoconstriction does not cause eosinophilic airway inflammation or airway hyperresponsiveness in subjects with asthma.
        Am J Respir Crit Care Med. 2000; 162: 1302-1307
        • Fitch K.D.
        • Sue-Chu M.
        • Anderson S.D.
        • Boulet L.P.
        • Hancox R.J.
        • McKenzie D.C.
        • et al.
        Asthma and the elite athlete: summary of the International Olympic Committee's consensus conference, Lausanne, Switzerland, January 22-24, 2008.
        J Allergy Clin Immunol. 2008; 122 (60.e1-7): 254-260
        • Langdeau J.B.
        • Turcotte H.
        • Bowie D.M.
        • Jobin J.
        • Desgagne P.
        • Boulet L.P.
        Airway hyperresponsiveness in elite athletes.
        Am J Respir Crit Care Med. 2000; 161: 1479-1484
        • Langdeau J.B.
        • Boulet L.P.
        Prevalence and mechanisms of development of asthma and airway hyperresponsiveness in athletes.
        Sports Med. 2001; 31: 601-616
        • Tsushima K.
        • Yasuo M.
        • Tanabe T.
        • Yoshikawa S.
        • Yamazaki Y.
        • Kubo K.
        Airway inflammation in employees involved in cultivating Japanese mushrooms (bunashimeji).
        Respirology. 2008; 13: 546-552
        • Carlsen K.H.
        Sports in extreme conditions: the impact of exercise in cold temperatures on asthma and bronchial hyper-responsiveness in athletes.
        Br J Sports Med. 2012; 46: 796-799
        • Bougault V.
        • Loubaki L.
        • Joubert P.
        • Turmel J.
        • Couture C.
        • Laviolette M.
        • et al.
        Airway remodeling and inflammation in competitive swimmers training in indoor chlorinated swimming pools.
        J Allergy Clin Immunol. 2012; 129 (8.e1): 351-358
        • Karjalainen E.M.
        • Laitinen A.
        • Sue-Chu M.
        • Altraja A.
        • Bjermer L.
        • Laitinen L.A.
        Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine.
        Am J Respir Crit Care Med. 2000; 161: 2086-2091
        • Helenius I.
        • Lumme A.
        • Haahtela T.
        Asthma, airway inflammation and treatment in elite athletes.
        Sports Med. 2005; 35: 565-574
        • Helenius I.
        • Rytila P.
        • Sarna S.
        • Lumme A.
        • Helenius M.
        • Remes V.
        • et al.
        Effect of continuing or finishing high-level sports on airway inflammation, bronchial hyperresponsiveness, and asthma: a 5-year prospective follow-up study of 42 highly trained swimmers.
        J Allergy Clin Immunol. 2002; 109: 962-968
        • Bougault V.
        • Turmel J.
        • Boulet L.P.
        Airway hyperresponsiveness in elite swimmers: is it a transient phenomenon?.
        J Allergy Clin Immunol. 2011; 127: 892-898
        • Rundell K.W.
        • Im J.
        • Mayers L.B.
        • Wilber R.L.
        • Szmedra L.
        • Schmitz H.R.
        Self-reported symptoms and exercise-induced asthma in the elite athlete.
        Med Sci Sports Exerc. 2001; 33: 208-213
        • Boulet L.P.
        • O'Byrne P.M.
        Asthma and exercise-induced bronchoconstriction in athletes.
        N Engl J Med. 2015; 372: 641-648
        • Anderson S.D.
        • Brannan J.D.
        Methods for “indirect” challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols.
        Clin Rev Allergy Immunol. 2003; 24: 27-54
        • Hancox R.J.
        • Subbarao P.
        • Kamada D.
        • Watson R.M.
        • Hargreave F.E.
        • Inman M.D.
        Beta2-agonist tolerance and exercise-induced bronchospasm.
        Am J Respir Crit Care Med. 2002; 165: 1068-1070
        • Ahrens R.C.
        • Milavetz G.
        • Joad J.
        The effect of theophylline and beta 2 agonists on airway reactivity.
        Chest. 1987; 92: 15S-21S
        • Parameswaran K.N.
        • Inman M.D.
        • Ekholm B.P.
        • Morris M.M.
        • Summers E.
        • O'Byrne P.M.
        • et al.
        Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonist.
        Am J Respir Crit Care Med. 1999; 160: 354-357
        • O'Byrne P.M.
        • van der Linde J.
        • Cockcroft D.W.
        • Gauvreau G.M.
        • Brannan J.D.
        • Fitzgerald M.
        • et al.
        Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma.
        J Allergy Clin Immunol. 2009; 124: 1217-1221
        • Juniper E.F.
        • Kline P.A.
        • Vanzieleghem M.A.
        • Ramsdale E.H.
        • O'Byrne P.M.
        • Hargreave F.E.
        Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics.
        Am Rev Respir Dis. 1990; 142: 832-836
        • Sont J.K.
        • Willems L.N.
        • Bel E.H.
        • van Krieken J.H.
        • Vandenbroucke J.P.
        • Sterk P.J.
        Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group.
        Am J Respir Crit Care Med. 1999; 159: 1043-1051
        • Cockcroft D.W.
        • Ruffin R.E.
        • Dolovich J.
        • Hargreave F.E.
        Allergen-induced increase in non-allergic bronchial reactivity.
        Clin Allergy. 1977; 7: 503-513
        • Cartier A.
        • Thomson N.C.
        • Frith P.A.
        • Roberts R.
        • Hargreave F.E.
        Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber.
        J Allergy Clin Immunol. 1982; 70: 170-177
        • Gauvreau G.M.
        • Watson R.M.
        • O'Byrne P.M.
        Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation.
        Am J Respir Crit Care Med. 1999; 160: 640-647
        • Gauvreau G.M.
        • Doctor J.
        • Watson R.M.
        • Jordana M.
        • O'Byrne P.M.
        Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation.
        Am J Respir Crit Care Med. 1996; 154: 1267-1271
        • Subbarao P.
        • Dorman S.C.
        • Rerecich T.
        • Watson R.M.
        • Gauvreau G.M.
        • O'Byrne P.M.
        Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy.
        J Allergy Clin Immunol. 2005; 115: 745-750
        • Leigh R.
        • Vethanayagam D.
        • Yoshida M.
        • Watson R.M.
        • Rerecich T.
        • Inman M.D.
        • et al.
        Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.
        Am J Respir Crit Care Med. 2002; 166: 1212-1217
        • Mattoli S.
        • Foresi A.
        • Corbo G.M.
        • Polidori G.
        • Ciappi G.
        Protective effect of disodium cromoglycate on allergen-induced bronchoconstriction and increased hyperresponsiveness: a double-blind placebo-controlled study.
        Ann Allergy. 1986; 57: 295-300
        • Boulet L.P.
        • Gauvreau G.
        • Boulay M.E.
        • O'Byrne P.
        • Cockcroft D.W.
        • Clinical Investigative Collaboration, Canadian Network of Centers of Excellence AllerGen
        The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies.
        Allergy. 2007; 62: 1101-1110
        • Duong M.
        • Cockcroft D.
        • Boulet L.P.
        • Ahmed T.
        • Iverson H.
        • Atkinson D.C.
        • et al.
        The effect of IVX-0142, a heparin-derived hypersulfated disaccharide, on the allergic airway responses in asthma.
        Allergy. 2008; 63: 1195-1201
        • Gauvreau G.M.
        • Watson R.M.
        • O'Byrne P.M.
        Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation.
        Am J Respir Crit Care Med. 1999; 159: 31-36
        • Gauvreau G.M.
        • Becker A.B.
        • Boulet L.P.
        • Chakir J.
        • Fick R.B.
        • Greene W.L.
        • et al.
        The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma.
        J Allergy Clin Immunol. 2003; 112: 331-338
        • Gauvreau G.M.
        • Boulet L.P.
        • Cockcroft D.W.
        • Baatjes A.
        • Cote J.
        • Deschesnes F.
        • et al.
        Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses.
        Am J Respir Crit Care Med. 2008; 177: 952-958
        • Gauvreau G.M.
        • Hessel E.M.
        • Boulet L.P.
        • Coffman R.L.
        • O'Byrne P.M.
        Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses.
        Am J Respir Crit Care Med. 2006; 174: 15-20
        • Gauvreau G.M.
        • Boulet L.P.
        • Cockcroft D.W.
        • Fitzgerald J.M.
        • Carlsten C.
        • Davis B.E.
        • et al.
        Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma.
        Am J Respir Crit Care Med. 2011; 183: 1007-1014
        • Gauvreau G.M.
        • Boulet L.P.
        • Schmid-Wirlitsch C.
        • Cote J.
        • Duong M.
        • Killian K.J.
        • et al.
        Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects.
        Respir Res. 2011; 12: 140
        • Gauvreau G.M.
        • Boulet L.P.
        • Cockcroft D.W.
        • FitzGerald J.M.
        • Mayers I.
        • Carlsten C.
        • et al.
        OX40L blockade and allergen-induced airway responses in subjects with mild asthma.
        Clin Exp Allergy. 2014; 44: 29-37
        • Boulet L.P.
        • Gauvreau G.M.
        • Cockcroft D.W.
        • Davis B.
        • Vachon L.
        • Cormier Y.
        • et al.
        Effects of ASM-024, a modulator of acetylcholine receptor function, on airway responsiveness and allergen-induced responses in patients with mild asthma.
        Can Respir J. 2015; 22: 230-234
        • Gauvreau G.M.
        • Boulet L.P.
        • FitzGerald J.M.
        • Cockcroft D.W.
        • Davis B.E.
        • Leigh R.
        • et al.
        A dual CysLT1/2 antagonist attenuates allergen-induced airway responses in subjects with mild allergic asthma.
        Allergy. 2016; 71: 1721-1727
        • Gauvreau G.M.
        • Harris J.M.
        • Boulet L.P.
        • Scheerens H.
        • Fitzgerald J.M.
        • Putnam W.S.
        • et al.
        Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production.
        Sci Transl Med. 2014; 6: 243ra85
        • Gauvreau G.M.
        • Boulet L.P.
        • Leigh R.
        • Cockcroft D.W.
        • Killian K.J.
        • Davis B.E.
        • et al.
        A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses.
        Am J Respir Crit Care Med. 2015; 191: 161-167
        • Gauvreau G.M.
        • O'Byrne P.M.
        • Boulet L.P.
        • Wang Y.
        • Cockcroft D.
        • Bigler J.
        • et al.
        Effects of an anti-TSLP antibody on allergen-induced asthmatic responses.
        N Engl J Med. 2014; 370: 2102-2110
        • Nair P.
        • Hanrahan J.
        • Hargreave F.E.
        Clinical equivalence testing of inhaled bronchodilators.
        Pol Arch Med Wewn. 2009; 119: 731-735
        • Chung K.F.
        • Wenzel S.E.
        • Brozek J.L.
        • Bush A.
        • Castro M.
        • Sterk P.J.
        • et al.
        International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.
        Eur Respir J. 2014; 43: 343-373
        • Aaron S.D.
        • Vandemheen K.L.
        • Boulet L.P.
        • McIvor R.A.
        • Fitzgerald J.M.
        • Hernandez P.
        • et al.
        Overdiagnosis of asthma in obese and nonobese adults.
        CMAJ. 2008; 179: 1121-1131
        • Pizzichini E.
        • Pizzichini M.M.
        • Efthimiadis A.
        • Hargreave F.E.
        • Dolovich J.
        Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination.
        Eur Respir J. 1996; 9: 1174-1180
        • Aleman F.
        • Lim H.F.
        • Nair P.
        Eosinophilic endotype of asthma.
        Immunol Allergy Clin North Am. 2016; 36: 559-568
        • Dasgupta A.
        • Neighbour H.
        • Nair P.
        Targeted therapy of bronchitis in obstructive airway diseases.
        Pharmacol Ther. 2013; 140: 213-222
        • Sadatsafavi M.
        • Lynd L.
        • Marra C.
        • Carleton B.
        • Tan W.C.
        • Sullivan S.
        • et al.
        Direct health care costs associated with asthma in British Columbia.
        Can Respir J. 2010; 17: 74-80
      2. Ontario Health Insurance Plan schedule of benefits [October 19, 2016]. Available from: http://www.health.gov.on.ca/en/pro/programs/ohip/sob/physserv/physserv_mn.html. Accessed December 31, 2016.

        • Hargreave F.E.
        • Nair P.
        The definition and diagnosis of asthma.
        Clin Exp Allergy. 2009; 39: 1652-1658